相关实验视频
Updated: Jan 7, 2026

12:03
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
12.9K
呈现为透性心肌质量的主要心脏发育肉瘤:一种罕见的病例,具有长期存活率
Ahmad Khajeh-Mehrizi1, Mehdi Karimi2,3, Masoud Mortezazadeh1
1Department of Hematology-Oncology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Journal of cardiothoracic surgery
|December 26, 2025
概括
初级心脏尤宁肉瘤 (ES) 是罕见的. 积极的多式疗法,包括手术,化疗和放射疗法,导致患有这种疾病的年轻成人患者的生存时间延长了36个月.
科学领域:
- 在瘤学瘤学.
- 心血管病理学心血管病理学
- 儿科瘤学 儿科瘤学
背景情况:
- 尤文肉瘤 (ES) 是一种罕见的小圆细胞瘤,主要影响儿童和年轻人的骨和软组织.
- 骨外表现的ES并不常见,初级心脏参与非常罕见.
- 在医学文献中,初级心脏尤宁肉瘤的病例报告有限.
研究的目的:
- 报告一个罕见的初级骨外心脏尤文瘤病例,发生在一个年轻人身上.
- 突出多式疗法在实现这种罕见疾病的延长生存时间方面的有效性.
- 强调在心内瘤的差异诊断中考虑心脏ES的重要性.
主要方法:
- 一名27岁的男性出现了宪法症状,并被诊断为心脏质量.
- 诊断评估包括临床评估,成像和活检,证实了原发性骨外心脏ES.
- 治疗涉及多模式的方法:手术切除,化疗和放射治疗.
主要成果:
- 该患者被诊断为右心室外流通道 (RVOT) 前面的质量.
- 患者在诊断后生存了36个月,超过了这种疾病的典型结果.
- 积极的多式疗法证明了延长生存的结果.
结论:
- 初级心脏尤宁肉瘤虽然罕见,但可以通过积极的多式联络疗法有效地管理.
- 早期诊断和干预对于改善心脏ES患者的治疗结果至关重要.
- 在心内瘤的差异诊断中应考虑尤宁肉瘤,特别是在具有全身症状的年轻患者中.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
360
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
360
Cardiomyopathy IV: Restrictive Cardiomyopathy
422
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
422
Cardiomyopathy II: Dilated Cardiomyopathy
431
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
431
Cardiomyopathy V: Interprofessional Care
310
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
310

